«上一篇/Previous Article|本期目录/Table of Contents|下一篇/Next Article»

《心脏杂志》[ISSN:1009-7236/CN:61-1268/R]

期数:

2017年第3期

页码:

307-312

栏目:

临床研究

出版日期:

2017-01-25

文章信息/Info

Title:

Prescription for reinforcing qi and activating blood in treatment of coronary heart diseases: a meta-analysis

作者:

张 莎¹; 李 哲²; 曹 亮¹; 贾承明¹; 王宗仁¹; 王 文¹

1.第四军医大学西京医院中医科，陕西 西安 710032；2.陕西中医药大学团委，陕西 咸阳 712046

Author(s):

ZHANG Sha¹;  LI Zhe²;  CAO Liang¹;  JIA Cheng-ming¹;  WANG Zong-ren¹;  WANG Wen¹

1.Department of Traditional Chinese Medicine, Xijing Hospital, Fourth Military Medical University, Xi’an 710032, Shaanxi, China; 2.League Committee, Shaanxi University of Traditional Chinese Medicine, Xianyang 712046, Shaanxi, China

关键词:

益气活血; 冠状动脉疾病; Meta分析; 有效性; 安全性

Keywords:

reinforcing qi and activating blood;  coronary disease;  meta-analysis;  curative effect;  safety

分类号:

R541.4

DOI:

-

文献标识码:

A

摘要:

目的 评价益气活血方药协同治疗冠心病的临床疗效、疗程及安全性。方法 检索PubMed、MEDLINE、web of science(SCI)和CBM、CNKI、VIP等数据库，并手工检索相关文献。运用RevMan 5.3软件对提取的有效数据进行Meta分析。结果 共纳入21项随机对照临床试验（RCT），合计3 306例研究对象。Meta分析结果显示：①中西结合组（益气活血方药联合西医常规治疗）与西医常规组（单纯的西医常规治疗）相比，其临床总疗效、心电图疗效和心绞痛疗效合并OR［95%CI］值分别为3.67 ［2.77，4.87］、1.86［1.42，2.44］和2.73 ［1.75，4.27］，均优于西医常规组，差异存在统计学意义（P<0.05）。②以30 d为分界，疗程28~30 d的文献占50%，从结果分析发现28~30 d组临床总疗效与>30 d的总疗效相当。③对纳入研究的3 306例冠心病病例进行不良反应/事件观察，中西结合组共出现2例不良反应/事件，均为胃部不适感，而西医常规组出现4例不良反应/事件，多为头晕、头胀、面红等。结论 在西医常规治疗基础上加用益气活血方药配伍治疗冠心病，在临床总疗效、心绞痛疗效和心电图疗效等方面，优于单纯的西医常规治疗，安全性较好。

Abstract:

AIM To evaluate the curative effect and safety of prescription for reinforcing qi and activating blood in treatment of coronary heart disease (CHD). METHODS Studies were identified by searching PubMed, MEDLINE, and Web of Science (SCI), CBM, CNKI and VIP databases. RevMan 5.3 software was used to extract the effective data for meta-analysis. RESULTS ①Twenty-one RCT studies were identified, including 3 306 patients. Compared with the Western medicine group (conventional Western medicine treatment), gross curative effect, electrocardiogram curative effect and angina pectoris curative effect with OR (95% CI) of the Chinese traditional medicine combined with the Westen medicine group (prescription for reinforcing qi and activating blood combined with conventional Western medicine treatment) were 3.67［2.77,4.87］, 1.86［1.42,2.44］ and 2.73［1.75,4.27］, respectively, which were statistically significant. ②Using 30 days as a separation time-point, the studies of the therapeutic period of 28-30 days accounted for 50%. Subgroup analyses of courses about gross curative effect showed that the therapeutic period of 28-30 days was as effective as that of >30 days in treating CHD. ③ Adverse drug reactions/events of the 3 306 patients enrolled with CHD were observed, with two cases of abdominal discomfort in the Chinese traditional medicine group combined with the Western medicine group vs. four cases mainly characterized by dizziness, headache, flushing, etc. in the Western medicine group. CONCLUSION Combination of reinforcing qi and activating blood prescription and basal conventional Western medicine in the treatment of CHD is superior to the latter alone in terms of total clinical efficacy and curative effects in angina pectoris and electrocardiogram as well as demonstrating a superior safety profile.

参考文献/References

[1]周文功,史加鑫.中医药治疗气虚血瘀型冠心病研究进展[J].亚太传统医药,2016,12(4):72-73.
[2]张秋雁,邓冰湘.冠心病心绞痛临床中医证型分布的回顾性分析[J].中医研究,2005,18(11):23-24.
[3]Nomenclature and criteria for diagnosis of ischemic heart disease. Report of the Joint International Society nd Federation of Cardiology/World Health Organization task force on standardization of clinical nomenclature[J].Circulation,1979,59(3):607-609.
[4]国家中医药管理局批准发布.《中医病证诊断疗效标准》[M].中国医药科技出版社,2012,11.
[5]代阿秋.益气活血汤治疗气虚血瘀型冠心病心绞痛疗效分析[J].今日健康,2015,14(4):102-103.
[6]葛立君.益气活血汤治疗气虚血瘀型冠心病稳定性心绞痛46例[J].福建中医药,2012,43(6):28-29.
[7]冷建春,张晓云,谭 燕.参七复脉方对气虚血瘀型急性心肌梗死患者颈动脉粥样硬化影响的临床研究[J].中国全科医学,2013,16(28):3397-3400.
[8]李 芾.益气活血汤治疗慢性稳定性心绞痛46例临床观察[J].湖南中医杂志,2015,31(7):39-40.
[9]罗水泉.益气活血通痹汤治疗冠心病心绞痛临床观察[J].中国中医急症,2014,23(7):1368-1369.
[10]马民凯,马会妙.益气活血汤治疗稳定型心绞痛临床疗效观察[J].中国中医急症,2013,22(12):2122-2123.
[11]苏 卫.益气活血方联合常规西药治疗冠心病心绞痛随机平行对照研究[J].实用中医内科杂志,2014,28(6):153-154.
[12]孙慧君,张登峰.益气活血逐瘀汤治疗冠心病心绞痛60例[J].中医研究,2013,26(10):24-25.
[13]覃松柏,刘 程,李 平,等.补肾益气活血方治疗冠心病心绞痛的临床观察[J].湖北中医杂志,2012,34(3):5-6.
[14]伍建光.从脾论治胸痹心痛66例[J].河南中医,2014,34(10):1915-1916.
[15]徐登峰.中医补气活血法治疗冠心病临床研究[J].亚太传统医药,2015,11(14):100-101.
[16]余宏伟,范绍荣.益气活血方治疗冠心病稳定型心绞痛疗效观察[J].中西医结合心脑血管病杂志,2012,10(2):136-137.
[17]钟 伟,邢庆盛,刘志刚,等.益气活血方治疗冠心病心绞痛临床研究[J].中医学报,2014,29(3):402-403.
[18]周 芹.益气活血法治疗老年冠心病心绞痛40例[J].河南中医,2015,35(9):2079-2081.
[19]莫志敏,孔 壮.益气活血逐瘀汤治疗冠心病心绞痛临床研究[J].河南中医,2015,35(8):1787-1789.
[20]李成林,卢健琪,潘朝锌,等.益气活血通络方治疗冠心病疗效及其对血管内皮功能和免疫调节的影响[J].广州中医药大学学报,2015,32(2):208-211.
[21]牛国民.自拟补气活血煎联合西药治疗稳定型心绞痛60例[J].环球中医药,2012,5(7):536-538.
[22]彭伟军,邢之华,廖 翔,等.益气活血法对冠心病稳定型心绞痛气虚血瘀证患者血清IL-6、TNF-α及ICAM-1的影响[J].湖南中医药大学学报,2011,31(7):49-51.
[23]张腊林,游运舸.中西医结合治疗冠心病心绞痛66例临床观察[J].中医药导报,2010,16(5):41-42.
[24]金克荣.探讨运用中医补气活血法治疗冠心病的临床效果[J].内蒙古中医药,2013,32(19):40-41.
[25]高 喜.中西医结合治疗冠心病的临床效果[J].中国实用医药,2014,9(5):18-19.

备注/Memo

备注/Memo:

收稿日期：2016-06-22.基金项目：国家自然科学基金项目资助(81373845) 通讯作者：王文，副教授，主要从事中西医防治冠心病基础与临床研究 Email：jinzhou@fmmu.edu.cn 作者简介：张莎，硕士生 Email：zhangsha@fmmu.edu.cn

常用功能

更新日期/Last Update: 2017-02-20